SCHEMBL2270834

SCHEMBL2270834

COCCCOCCCOCCCO

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.46
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
THRB P10828 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 5/20 0.36
GAA P10253 2/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.31
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24505431 1.00 TSHR (0.46) TSHRMEN1KMT2ATHRBHTT
SCHEMBL642382 1.00 TSHR (0.46) TSHRMEN1KMT2ATHRBHTT
SCHEMBL10057440 0.97 MEN1 (0.44) TSHRMEN1KMT2ATHRBHTT
SCHEMBL4432440 0.97 MEN1 (0.44) TSHRMEN1KMT2ATHRBHTT
SCHEMBL4400496 0.94 MEN1 (0.46) TSHRMEN1KMT2ATHRBHTT
SCHEMBL29319882 0.92 MEN1 (0.44) TSHRMEN1KMT2ATHRBHTT
SCHEMBL29319832 0.92 MEN1 (0.44) TSHRMEN1KMT2ATHRBHTT
SCHEMBL31608767 0.92 MEN1 (0.44) TSHRMEN1KMT2ATHRBHTT
SCHEMBL22266288 0.92 MEN1 (0.50) TSHRMEN1KMT2ATHRBHTT
SCHEMBL4394179 0.92 MEN1 (0.44) TSHRMEN1KMT2ATHRBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295203-A1 METAL ORGANIC COMPOUNDS UMICORE AG & CO. KG (DE) 2023-09-21 US claimed
US-20230192736-A1 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2023-06-22 US claimed
EP-4126889-A1 METAL ORGANIC COMPOUNDS Umicore AG & Co. KG (DE) 2023-02-08 EP claimed
EP-3720835-B1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS BASF SE (DE) 2022-07-13 EP claimed
US-11078146-B2 Method for preparing ethers of cycloaliphatic or araliphatic diols BASF SE (DE) 2021-08-03 US claimed
US-20210171427-A1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS BASF SE (DE) 2021-06-10 US claimed
EP-3720835-A1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS BASF SE (DE) 2020-10-14 EP claimed
CN-111479795-A Process for preparing ethers of cycloaliphatic or araliphatic diols 巴斯夫欧洲公司 2020-07-31 CN claimed
WO-2019110464-A1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS BASF SE (DE) 2019-06-13 WO claimed
US-8003588-B2 Composition and method using same to remove urethane products from a substrate Tepolt, Danny P. (US) 2011-08-23 US claimed
US-20090264331-A1 COMPOSITION AND METHOD USING SAME TO REMOVE URETHANE PRODUCTS FROM A SUBSTRATE Tepolt, Danny P. (US) 2009-10-22 US claimed
EP-1888495-A4 COMPOSITION AND METHOD USING SAME TO REMOVE URETHANE PRODUCTS FROM A SUBSTRATE TEPOLT NANCY M (US) 2009-07-08 EP claimed
EP-1888495-A2 COMPOSITION AND METHOD USING SAME TO REMOVE URETHANE PRODUCTS FROM A SUBSTRATE Tepolt, Nancy M. (US) 2008-02-20 EP claimed
WO-2006124394-A2 COMPOSITION AND METHOD USING SAME TO REMOVE URETHANE PRODUCTS FROM A SUBSTRATE TEPOLT, DANNY, P. (US) 2006-11-23 WO claimed
US-20060186379-A1 Composition and method using same to remove urethane products from a substrate TEPOLT, DANNY P. 2006-08-24 US claimed
US-4119605-A MONOETHER OF DIETHYLENE GLYCOL OR TRIETHYLENE GLYCOL SCHENECTADY CHEMICALS, INC. (US) 1978-10-10 US claimed
US-4119608-A MONOETHER OF DIETHYLENE GLYCOL OR TRIETHYLENE GLYCOL SCHENECTADY CHEMICALS, INC. (US) 1978-10-10 US claimed
US-4119758-A Electrical conductors having insulating coatings from solutions of polyester-imides SCHENECTADY CHEMICALS, INC. (US) 1978-10-10 US claimed
EP-4711434-A1 REFRIGERANT CYCLE APPARATUS Daikin Industries, Ltd. (JP) 2026-03-18 EP disclosed
US-5990234-A Coating composition BTG, A PARTNERSHIP 1999-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171427-A1 METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS DGKI, MGLL, DEGS1 TSHR 2908/4885MEN1 876/4885KMT2A 2893/4885
US-20230295203-A1 METAL ORGANIC COMPOUNDS SCO2, MLX, PYM1 TSHR 4643/4885MEN1 641/4885KMT2A 1189/4885
US-11078146-B2 Method for preparing ethers of cycloaliphatic or araliphatic diols DGKI, MGLL, DEGS1 TSHR 2908/4885MEN1 876/4885KMT2A 2893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.